Encephalitis Vaccination Market Size, Share, Growth, and Industry Analysis, By Type (Encephalitis B Vaccine, Encephalitis Attenuated Live Vaccine), By Application (Public Hospital, Private Hospital, Clinic, Other), Regional Insights, and Forecast To 2031

Encephalitis Vaccination Market Report Overview

• 

•  Request a Free Sample to learn more about this report

The global Encephalitis Vaccination Market size was US$ 1291.2 million in 2021 and is projected to touch US$ 2236.58 million by 2031, exhibiting a CAGR of 5.6% during the forecast period. 

The encephalitis virus is a mosquito-borne Flavivirus that spreads through an enzootic cycle by multiplying vertebrate hosts like pigs and wading birds. Immunisations make avoiding it straightforward. In Asia-Pacific, it is the main source of encephalitis. A mosquito bite can easily cause someone to contract the encephalitis virus, which is more common in rural agricultural settings. Though it can happen for differing lengths of time, in various locations, and during various activities, there is a very low risk of contracting the encephalitis virus. The high mortality and morbidity rate brought on by the presence of the encephalitis virus is a major driver propelling the market's expansion.

COVID-19 Impact: Imposed Restrictions in the Economy Resulted in Decline in the Market

The global COVID-19 pandemic has been unprecedented and staggering, with the Global Encephalitis Vaccination Market experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden rise in CAGR is attributable to market’s growth and demand returning to pre-pandemic levels.

The COVID-19 outbreak caused temporary business closures as well as supply chain and manufacturing disruptions, which in turn reduced the development of telecom infrastructure and had a negative effect on the sales and marketing efforts of rugged phone companies competing in the market. The effects were severe, particularly for startups and small- to medium-sized businesses operating in this industry. Companies did, however, make a lot of restructuring efforts to address the supply chain difficulties and improve collaboration with suppliers and partners to lessen the negative market impact.

LATEST TRENDS

"Growth of the market in recent years"

A virus called Japanese encephalitis attacks the brain and is transmitted through mosquito bites. The Far East, the Pacific Islands, and rural Southeast Asia are where it is most prevalent, although travellers are hardly ever exposed to it. Pigs and birds can carry the virus, which mosquitoes pick up by biting infected hosts. Less than one traveller in a million is thought to acquire Japanese encephalitis each year. According to the World Health Organisation (WHO), 68,000 cases of Japanese encephalitis are reported worldwide each year. Particularly at risk are people who reside in and work in rural settings like pig farms and rice fields. Children under 15 are involved in almost 75% of the cases.

Encephalitis Vaccination Market Segmentation

• 

•  Request a Free Sample to learn more about this report

• By Type

Based on type the global encephalitis vaccination market is classified as encephalitis b vaccine, encephalitis attenuated live vaccine.

• By Application

Based on application the global encephalitis vaccination market is classified as public hospital, private hospital, clinic, other.

DRIVING FACTORS

"The Utilization as a Catalyst to Boost the Market Growth "

The high mortality and morbidity rate brought on by the prevalence of the encephalitis virus is the main reason contributing to the market's expansion. Additionally, the sector is being helped by rising government initiatives for immunization campaigns. For instance, 37 human cases of Japanese encephalitis had been reported in four Australian states as of April 28, 2022, according to the World Health Organization. In addition, a study titled "Global magnitude of encephalitis burden and its evolving pattern over the past 30 years" released in June 2022 found that encephalitis caused 4.80 million DALYs and 1,444,720 incident cases globally in 2019. People must take preventive measures like vaccination as the number of cases and fatalities rises, which raises the demand for encephalitis vaccinations.

"Extensive Application in Laundering Process to Multiply the Production and Market Growth"

Additionally, several tactics used by the major market participants, including product launches, mergers, and acquisitions, are anticipated to boost market expansion. For instance, Pfizer Inc. announced in August 2021 that the US Food and Drug Administration (FDA) had approved the TICOVAC (tick-borne encephalitis (TBE) vaccine) for active immunization to prevent TBE in people 1 year of age and older. One of the first vaccines FDA-approved to help shield American adults and kids from the TBE virus when travelling to or residing in TBE endemic locations is TICOVAC.The industry is therefore anticipated to have significant expansion over the upcoming years as a result of the aforementioned factors. The adverse reactions and technical difficulties associated with the vaccination, however, limit market expansion. The encephalitis vaccine is a useful tool for preventing pandemic encephalitis. An acute viral condition of the central nervous system was brought on by the je virus, an arbovirus that is yellow in colour. frequently end in death or neurological aftereffects. Je is a zoonotic illness that mosquitoes can transmit. After encephalitis virus infection, people and numerous animals could become infection sources.

RESTRAINING FACTORS

"Several Challenges Associated with the Local Irritation to Restrain the Market"

The market's growth is anticipated to be constrained by the adverse reactions or consequences linked to encephalitis vaccines. For instance, patients who received the JE vaccine can report soreness, discomfort, redness, or swelling at the injection site. Fever can strike at any time, however youngsters are particularly susceptible. Muscle aches and headaches are possible, mainly in adults. According to studies, severe reactions to the JE vaccine are incredibly uncommon. A vaccine has a slight risk of triggering a severe allergic reaction, other life-threatening complications, or death, just like any other drug. Most of the time, vaccinations are straightforward procedures that safeguard populations from terrible illnesses like tuberculosis, measles, and influenza. However, a vaccine may have unintended consequences for some patients, such as subsequent encephalitis.

Encephalitis Vaccination Market Regional Insights

• 

•  Request a Free Sample to learn more about this report

"North American Region to Dominate the Market with Extensive Utilization and Multiplying Manufacturers"

Over the course of the projected period, the Asian market is anticipated to expand rapidly. Asia is where Japanese encephalitis is most prevalent. The Japanese encephalitis virus is present in Asia and Oceania, from Japan to India, Pakistan, and Australia, according to information from the European Centre for Disease Prevention and Control in March 2022. Events that are geographically and temporally limited, unpredictable, and chaotic are outbreaks. Each year, between 30,000 and 50,000 cases are reported, making the virus a common cause of viral encephalitis in Asia. As a result, the forecasted market growth was favourably impacted by the rising encephalitis incidence in the area.

KEY INDUSTRY PLAYERS

"Financial Players to Contribute Towards Expansion of Market"

This market is extremely competitive and consists of various global and regional players. Major players are involved in strategizing various plans such as mergers and acquisitions, partnerships, introduction of new and enhanced products, along with joint ventures. The report is extensive research of a list of market players who contribute towards the expansion of the market. The information is a collusion of latest technological developments, trends, production lines mergers and acquisitions, market study and others. Other factors such as regional wise analysis and segment wise analysis are also considered to understand the market share, product growth, revenue growth and others during the forecasted period.

LIST OF TOP ENCEPHALITIS VACCINATION COMPANIES

• Novartis (Switzerland)
• Sanofi (France)
• Chengdu Institute of Biological Products (China)
• Wuhan Institute of Biological Products (China)
• Lanzhou Institute of Biological Products (China)
• Beijing Taitan (China)
• Valneva (France)
• Bharat Biotech (India)
• Liaoning Chengda (China)

REPORT COVERAGE

The SWOT analysis and information on future developments are covered in the study. The research report includes a study of several factors that promote market growth. This section also covers the range of numerous market categories and applications that could potentially affect the market in the future. The specifics are based on current trends and historical turning points. The state of the market's components and its potential growth areas over the following years. The paper discusses market segmentation information, including subjective and quantitative research, as well as the impact of financial and strategy opinions. Additionally, the research disseminates data on national and regional assessments that take into account the dominant forces of supply and demand that are influencing market growth. The competitive environment, including market shares of significant competitors, is detailed in the report along with fresh research methodology and player strategies for the anticipated time.